Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease
Neurogastroenterology & Motility · 2025-12 · 37 (12)
DOI: 10.1111/nmo.70117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 04.08.2025. Verfasst von N A Koloski und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Health, Medicine and Well-Being, University of Newcastle, Callaghan, New South Wales, Australia. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Inflammatory Bowel Diseases, Brain-Gut Axis, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AusEE Inc.
Abstract (Originalsprache)
Background
Apart from disorders of gut‐brain interaction (DGBI), little data exist on the magnitude of the brain‐to‐gut pathway in other chronic gastrointestinal conditions such as gastroesophageal reflux disease (GERD) or inflammatory bowel disease (IBD) and what factors modify order of diagnosis. We aimed to determine the proportion of patients who received a diagnosis of a DGBI, GERD, or IBD prior to a new psychological diagnosis (gut‐to‐brain), and vice versa (brain‐to‐gut), and whether specific factors moderate the order of diagnosis.
Method
Data was collected from a retrospective study of 1,129,104 patients attending general practices in the United Kingdom. Patients diagnosed with DGBI, GERD, or IBD and a psychological disorder (anxiety and/or depression) were included (excluding those with other organic GI disease). Information on which diagnosis appeared first was recorded. Multiple logistic regression was performed to compare a diagnosis of a DGBI, GERD, or IBD first versus a psychological diagnosis first on sociodemographic factors, medical conditions, and medication usage. Key Results Just over half of patients were diagnosed with a psychological condition first versus after for IBS (53.9%) and ulcerative colitis (55.6%). This proportion was higher for FD (61.5%) and GERD (64.2%) but lower for Crohn's disease (45.7%). In a multivariate model, being female (OR = 1.37, 95% CI 1.25, 1.49), prior PPI (OR = 9.17, 95% CI 8.4, 10.0), antibiotic (OR = 2.54, 95% CI 2.29, 2.81) and NSAID use (OR = 1.29, 95% CI 1.18, 1.42), and prior gastroenteritis (OR = 2.19, 95% CI, 1.79, 2.67) were significant predictors for being diagnosed with GERD first. Similar results were found for DGBI. Conclusions & Inferences Prior medication usage and gastroenteritis may play a role in generating gut‐to‐brain pathway disturbances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Health, Medicine and Well-Being, University of Newcastle, Callaghan, New South Wales, Australia.
- Department of Gastroenterology & Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- University of Queensland, Faculty of Health & Behavioural Sciences, St. Lucia, Queensland, Australia.
- Department of Psychology, Macquarie University, Sydney, New South Wales, Australia.
- University of Queensland, Faculty of Medicine, St. Lucia, Queensland, Australia.
ORCID-Profile: N A Koloski, M P Jones, N J Talley
Förderung
- AusEE Inc
Zitieren
APA
Koloski, N. A., Jones, M. P., Shah, A., Holtmann, G., & Talley, N. J. (2025). Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease. Neurogastroenterology & Motility, 37(12). https://doi.org/10.1111/nmo.70117
Vancouver
Koloski NA, Jones MP, Shah A, Holtmann G, Talley NJ. Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease. Neurogastroenterology & Motility. 2025;37(12). doi:10.1111/nmo.70117
BibTeX
@article{Koloski2025,
author = {Koloski, N A and Jones, M P and Shah, A and Holtmann, G and Talley, N J},
title = {Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease},
journal = {Neurogastroenterology & Motility},
year = {2025},
volume = {37},
number = {12},
doi = {10.1111/nmo.70117}
}
EUVIMED